Product Name Ferric carboxymaltose
CAS Number 9007-72-1
Formula C18H31FeO15
Molar Mass 497.18 g/mol
Pub Chem CID 9856429
Drug Bank DB09145
Chem Spider 8034553
Bioavailability Approximately 100%
Protein Binding Very low
Metabolism Minimal metabolism
Elimination Halflife Approximately 7 hours
FAQ
What is ferric carboxymaltose and how does it work in the body?

Ferric carboxymaltose is an intravenous iron replacement therapy used to treat iron deficiency anemia in adult patients. It works by replenishing iron stores in the body, which are essential for the production of hemoglobin – the protein in red blood cells responsible for carrying oxygen throughout the body. By providing iron in a form that can be easily absorbed and utilized by the body, ferric carboxymaltose helps to correct the deficiency and improve symptoms of anemia such as fatigue, weakness, and shortness of breath.

Who is a suitable candidate for ferric carboxymaltose treatment?

Ferric carboxymaltose is typically recommended for adult patients with iron deficiency anemia who are unable to tolerate or have not responded to oral iron supplements. It may also be used in individuals who require rapid replenishment of iron stores due to severe anemia or other underlying medical conditions. Your healthcare provider will assess your iron levels and overall health status to determine if ferric carboxymaltose is a suitable treatment option for you.

What are the potential side effects of ferric carboxymaltose treatment?

Common side effects of ferric carboxymaltose may include headache, dizziness, nausea, vomiting, and injection site reactions. In some cases, patients may experience more serious side effects such as allergic reactions, low blood pressure, or iron overload. It is important to discuss any concerns or symptoms with your healthcare provider promptly to ensure appropriate management of side effects and continued safe use of ferric carboxymaltose.

How is ferric carboxymaltose administered and what should I expect during treatment?

Ferric carboxymaltose is administered intravenously by a healthcare professional in a clinical setting such as a hospital or infusion center. The dosage and duration of treatment will be determined by your healthcare provider based on your individual needs and response to therapy. During the infusion, you may experience mild discomfort or a metallic taste in your mouth, but these symptoms typically subside once the infusion is complete. It is important to follow all instructions provided by your healthcare provider and report any unusual symptoms or concerns during treatment.

Are there any precautions or contraindications for ferric carboxymaltose treatment?

Ferric carboxymaltose should not be used in patients with a history of hypersensitivity to iron products, certain blood disorders, or significant iron overload. It is important to inform your healthcare provider about any medical conditions, allergies, medications, or supplements you are taking before starting treatment with ferric carboxymaltose. Additionally, pregnant or breastfeeding women should consult with their healthcare provider before undergoing treatment with ferric carboxymaltose to ensure the safety of both mother and baby.
Back
Become a customer
If you have any questions about our products and services, please contact us at 0086-25-52397803 or mail to info@fidaxomicin-ascomycin.com.
We will reply to you as soon as possible.
Get a quick quote
Click For Help
Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.